Stay up to date with the latest Synexa news and updates.

Latest updates

Synexa Life Sciences announces the integration of the Olink® Target immunoassays and the Olink® Signature Q100 instrument into its extensive suite of biomarker discovery platforms.

March 4, 2024

The visit highlighted the importance of South Africa and Synexa Life Sciences as partners in the CEPI (Coalition for Epidemic Preparedness Innovations) mission to accelerate the development of vaccines and other biologic countermeasures against epidemic and pandemic threats.

February 9, 2024

Synexa joins CEPI’s esteemed Central Lab Network to improve global epidemic preparedness.

May 30, 2023

Two decades of advancing drug development programs through specialist biomarker and bioanalytical insights.

March 3, 2023

Leading specialist biomarker and bioanalysis solutions provider further strengthens global management team.

August 19, 2022

New site supports unique and seamless workflows that narrow the gap between preclinical and clinical phases

June 13, 2022